title: Comparative effects of indomethacin and nabumetone on urine and electrolyte output in conscious rats.
abstract: The effects of indomethacin and nabumetone on urine and electrolyte excretion in conscious rats were examined. Male Sprague-Dawley rats were housed individually for a five-week duration, consisting of acclimatization, control, experimental, and recovery phases. During the experimental phase, rats were given either indomethacin (1.5 mg . kg(-1) body weight . day(-1) in 0.5 ml saline, n = 10), nabumetone (15 mg . kg(-1) body weight . day(-1) 0.5 ml saline, n = 10), or 0.5 ml saline alone (n = 10) for a period of two weeks. Water and food intake, body weight, urine output, and electrolyte excretions were estimated. Data were analyzed using two-way ANOVA. Urine output in the indomethacin- and nabumetone-treated groups was not different from the controls, but was significantly different between the drug-treated groups (P<0.01). Sodium, potassium, calcium, and magnesium excretions were not different between nabumetone-treated and control rats. However, sodium and potassium excretion was significantly lower in rats receiving indomethacin when compared to the control rats. Calcium and magnesium outputs, although did not differ from the controls, nevertheless decreased significantly with indomethacin (P<0.01). It appears that indomethacin and nabumetone when given at maximum human therapeutic doses may affect urine and electrolyte output in conscious rats.
authors.affiliation: Department of Physiology, School Medical Sciences, University Sains Malaysia, Kelantan, Malaysia.
authors.forename: Idris
authors.initials: I
authors.lastname: bin Long
authors.forename: Harbindar Jeet
authors.initials: HJ
authors.lastname: Singh
authors.forename: Gurubelli Janardhana
authors.initials: GJ
authors.lastname: Rao
mesh_terms: D000818:Animals; D002074:Butanones / Q000494:pharmacology*; D051545:Cyclooxygenase 1; D051546:Cyclooxygenase 2 / Q000187:drug effects; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology*; D004573:Electrolytes / Q000652:urine*; D007213:Indomethacin / Q000494:pharmacology*; D007668:Kidney / Q000187:drug effects* / Q000502:physiology; D008297:Male; D008565:Membrane Proteins / Q000037:antagonists & inhibitors; D000077430:Nabumetone; D051381:Rats; D017207:Rats, Sprague-Dawley; D014554:Urination / Q000187:drug effects*
chemical_list: D002074:Butanones; D016861:Cyclooxygenase Inhibitors; D004573:Electrolytes; D008565:Membrane Proteins; D051545:Cyclooxygenase 1; D051546:Cyclooxygenase 2; C496513:Ptgs1 protein, rat; C489691:Ptgs2 protein, rat; D000077430:Nabumetone; D007213:Indomethacin